Enteropathy type T cell lymphoma with an unusually late relapse: a case report
- M Al Kaptan1,
- D Hui2,
- L Dabbagh3,
- T Reiman4,
- R Lai5
- 1Department of Laboratory Medicine and Pathology, University of Alberta and Cross Cancer Institute, Edmonton, Alberta, Canada
- 2Department of Medicine, University of Alberta and Cross Cancer Institute, Edmonton, Alberta, Canada
- 3Department of Laboratory Medicine and Pathology, University of Alberta and Cross Cancer Institute, Edmonton, Alberta, Canada
- 4Department of Medicine, University of Alberta and Cross Cancer Institute, Edmonton, Alberta, Canada
- 5Department of Laboratory Medicine and Pathology, University of Alberta and Cross Cancer Institute, Edmonton, Alberta, Canada
- Correspondence to:
Dr R Lai
Department of Laboratory Medicine and Pathology, University of Alberta and Cross Cancer Institute, 11560 University Avenue, Edmonton, Alberta, Canada T69 I22; raymondl{at}cancerboard.ab.ca
- Accepted 22 February 2006
Enteropathy type T cell lymphoma (ETTL) is a rare subtype of T cell lymphoma that is strongly associated with coeliac disease.1 The overall prognosis is poor. In one study, 15 of 19 (79%) patients relapsed within 60 months after the initial diagnosis (median, 6 months), and the overall survival rate at 5 years was 24%.2 We describe a case of ETTL with an unusually late relapse. The patient was a 50-year-old woman who developed an ulcerated gastric tumour in 1992, with no associated lymphadenopathy or hepatosplenomegaly. A partial gastrectomy was performed, and at the time of surgery, the tumour …
